Ischemic heart disease in patients with COPD

N. Karoli, A. Rebrov (Saratov, Russian Federation)

Source: Annual Congress 2007 - COPD and comorbidity
Session: COPD and comorbidity
Session type: Electronic Poster Discussion
Number: 4150
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Ischemic heart disease (IHD) is most wide-spread disease in adult people. Little is known about its combination with COPD. We study frequency and peculiarity of IHD in patients with COPD.
Materials and methods. 233 patients with COPD have been studied (aged 55,2±0,61): 74 patients with mild and moderate COPD and 159 patients with severe COPD. Diagnosis of COPD was made according to the ERS standards. Diagnosis IHD was made if patients have myocardial infarction (MI) and angina pectoris.
Results. 28.8% patients have IHD: MI in 33 patients, angina pectoris in 30 patients. NonQ-infarct was in 17 patients, Q-infarct – in 16 patients. 17 patients (51.5%) with MI have non-pain infarction, 54.2% have anterior infarction, 45.8% - ihferior MI. All patients divided in 2 groups: with and without IHD. Patients with IHD was higher (p<0.001), have more severe bronchial obstruction (p<0.01), duration and intensity of smoking (p<0.001 and p<0.01) than patients without IHD. But patients with IHD did not differ from patients without IHD on body mass index, level of cholesterol, frequency of arterial hypertension. Patients with severe COPD have MI in 2.1 times more than patients with mild and moderate COPD (17.1% and 8%). Patients with IHD has 1.6 times more CRP> 3mg/l than patients without IHD (42.3% and 26%). There are correlations between CRP and FEV1 in patients with IHD (r=-0.44, p<0.05), mainly in patients with MI (r=-0.81, p<0.01).
Conclusions. The data presented in this study indicate that COPD, especially with severe bronchial obstruction, associated with ischemic heart disease independent other risk factor of IHD. Age, FEV1, duration and intensity of smoking, systemic inflammation (CRP) are associated with coronary disease in patents with COPD.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Karoli, A. Rebrov (Saratov, Russian Federation). Ischemic heart disease in patients with COPD. Eur Respir J 2007; 30: Suppl. 51, 4150

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Heart arrhythmias in patients with chronic obstructive bronchitis and ischemic heart disease
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004

COPD in heart failure patients
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease
Source: Eur Respir J 2006; 28: Suppl. 50, 162s
Year: 2006

Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Underlying ischaemic heart disease assessed by cardiac infarction injury score (CIIS) is under-recognised in our patients hospitalised for COPD exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Prevalence and characteristics of congestive heart failure in elderly patients with chronic lung disease
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Study of heart rate variability in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


COPD prevalence in chronic heart failure
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019

Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Relationships between exacerbation symptoms, recovery and ischaemic heart disease in COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Exercise heart rate recovery in chronic obstructive pulmonary disease patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010


Neglected COPD and chronic comorbidities in elderly patients with chronic heart failure
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008


Mechanisms of Cardiac arrhythmias in patients with chronic obstructive disease (COPD)
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018